LONDON & BOSTON–(BUSINESS WIRE)–MVM Life Science Partners today announced the closing of a $233 million healthcare fund, MVM IV. The fund is MVM’s fourth and largest raised to date. MVM IV is investing in medical companies, principally in Europe and the United States. The fund invests broadly across the healthcare field including in technologies, therapeutics, […]